Liminatus Pharma, Inc. Class A Common Stock
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $6.2M
- Price
- $0.1165
- % Change (Daily % change from the live per-ticker quote feed.)
- -5.28%
- Volume
- 6.6M
Quote data as of 6:14 AM ET
About
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
Quick stats
Shares outstanding50.6M
Computed float33.5M
Float sourceUnknown
Cash runway (months)2.4
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001971387
Websitehttps://liminatuspharma.com